{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:17:01Z","timestamp":1773955021070,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sociedade Brasileira Hepatologia"},{"name":"Instituto Brasileiro do F\u00edgado"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10620-021-07122-y","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T15:03:05Z","timestamp":1624892585000},"page":"3305-3312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7824-2152","authenticated-orcid":false,"given":"Guilherme Grossi Lopes","family":"Can\u00e7ado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Harriz","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lucia Gomes","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane Alves","family":"Villela-Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora Raquel Benedita","family":"Terrabuio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Luiz Rachid","family":"Can\u00e7ado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateus Jorge","family":"Nardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Costa","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia Mota","family":"de Faria Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elze Maria Gomes","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Rotman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Beatriz","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone Muniz Carvalho Fernandes","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlone","family":"Cunha-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana Sampaio Costa","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Alexandra Pontes","family":"Ivantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana","family":"Codes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria Ferreira","family":"de Almeida e Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Heleno","family":"de Lima Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Guimar\u00e3es","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabelle Venturini","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Perdomo","family":"Coral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Lisboa","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia Alves","family":"Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Members of the Brazilian Cholestasis Study Group Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"7122_CR1","doi-asserted-by":"crossref","unstructured":"Lleo A, Wang G-Q, Gershwin ME, Hirschfield GM. Primary biliary cholangitis. Lancet (London, England) 2020; 396:1915\u20131926.","DOI":"10.1016\/S0140-6736(20)31607-X"},{"key":"7122_CR2","doi-asserted-by":"crossref","unstructured":"Leung KK, Deeb M, Hirschfield GM. Review article: pathophysiology and management of primary biliary cholangitis. Aliment Pharmacol. Ther. 2020; 52:1150\u20131164.","DOI":"10.1111\/apt.16023"},{"key":"7122_CR3","doi-asserted-by":"crossref","unstructured":"Lindor KD, Bowlus CL, Boyer J et al. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019; 69:394\u2013419.","DOI":"10.1002\/hep.30145"},{"key":"7122_CR4","doi-asserted-by":"publisher","unstructured":"Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in Autoimmune Liver Disease\u2014Clinical and Diagnostic Relevance. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.00609.","DOI":"10.3389\/fimmu.2018.00609"},{"key":"7122_CR5","doi-asserted-by":"crossref","unstructured":"Hurlburt KJ, McMahon BJ, Deubner H et al. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol. 2002; 97:2402\u20137.","DOI":"10.1111\/j.1572-0241.2002.06019.x"},{"key":"7122_CR6","doi-asserted-by":"crossref","unstructured":"Arbour L, Rupps R, Field L et al. Characteristics of primary biliary cirrhosis in British Columbia\u2019s First Nations population. Can. J. Gastroenterol. 2005; 19:305\u201310.","DOI":"10.1155\/2005\/203028"},{"key":"7122_CR7","doi-asserted-by":"crossref","unstructured":"Muratori P, Muratori L, Gershwin ME et al. \u201cTrue\u201d antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol. 2004; 135:154\u20138.","DOI":"10.1111\/j.1365-2249.2004.02332.x"},{"key":"7122_CR8","doi-asserted-by":"crossref","unstructured":"Selmi C, Zuin M, Bowlus CL, Gershwin ME. Anti-mitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis. 2008; 12:173\u201385, ix.","DOI":"10.1016\/j.cld.2007.11.008"},{"key":"7122_CR9","doi-asserted-by":"crossref","unstructured":"Mattalia A, Quaranta S, Leung PS et al. Characterization of antimitochondrial antibodies in health adults. Hepatology. 1998; 27:656\u201361.","DOI":"10.1002\/hep.510270303"},{"key":"7122_CR10","doi-asserted-by":"crossref","unstructured":"Cunha LM, Bittencourt PL, Abrantes-Lemos CP et al. Prevalence of non-organ-specific autoantibodies in a rural community from northeastern Brazil: a population-based study. Hum Immunol. 2012; 73:70\u20134.","DOI":"10.1016\/j.humimm.2011.10.001"},{"key":"7122_CR11","doi-asserted-by":"crossref","unstructured":"Shibata M, Onozuka Y, Morizane T et al. Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture. J Gastroenterol. 2004; 39:255\u20139.","DOI":"10.1007\/s00535-003-1285-6"},{"key":"7122_CR12","doi-asserted-by":"crossref","unstructured":"Farias AQ, Goncalves LL, Bittencourt PL et al. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial\/anti-M2 seropositive variant form of autoimmune hepatitis. J Gastroenterol Hepatol. 2006; 21:887\u2013893.","DOI":"10.1111\/j.1440-1746.2006.04130.x"},{"key":"7122_CR13","doi-asserted-by":"crossref","unstructured":"Sun C, Xiao X, Yan L et al. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker? J Autoimmun. 2019; 99:33\u201338.","DOI":"10.1016\/j.jaut.2019.01.005"},{"key":"7122_CR14","doi-asserted-by":"crossref","unstructured":"Metcalf J V., Mitchison HC, Palmer JM et al. Natural history of early primary biliary cirrhosis. Lancet (London, England) 1996; 348:1399\u2013402.","DOI":"10.1016\/S0140-6736(96)04410-8"},{"key":"7122_CR15","doi-asserted-by":"publisher","unstructured":"Mitchison HC, Bassendine MF, Hendrick A et al. Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis? Hepatology. 1986. https:\/\/doi.org\/10.1002\/hep.1840060609.","DOI":"10.1002\/hep.1840060609"},{"key":"7122_CR16","doi-asserted-by":"crossref","unstructured":"Dahlqvist G, Gaouar F, Carrat F et al. Large-scale characterization study of patients with antimitochondrial antibodies but non established primary biliary cholangitis. Hepatology. 2017; 65:152\u2013163.","DOI":"10.1002\/hep.28859"},{"key":"7122_CR17","doi-asserted-by":"crossref","unstructured":"Zandanell S, Strasser M, Feldman A, Tevini J, Strebinger G, Niederseer D, Pohla-Gubo G, Huber-Sch\u00f6nauer U, Ruhaltinger S, Paulweber B, Datz C, Felder TK, Aigner E. Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up. J Intern Med. 2020 Apr;287:395-404.","DOI":"10.1111\/joim.13005"},{"key":"7122_CR18","doi-asserted-by":"crossref","unstructured":"Oertelt S, Rieger R, Selmi C et al. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology. 2007; 45:659\u201365.","DOI":"10.1002\/hep.21583"},{"key":"7122_CR19","doi-asserted-by":"crossref","unstructured":"Liu B, Shi XH, Zhang FC et al. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. Liver Int. 2008; 28:233\u20139.","DOI":"10.1111\/j.1478-3231.2007.01651.x"},{"key":"7122_CR20","doi-asserted-by":"crossref","unstructured":"Mendes F, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol Clin North Am. 2008; 37:479\u201384, viii.","DOI":"10.1016\/j.gtc.2008.02.006"},{"key":"7122_CR21","doi-asserted-by":"publisher","unstructured":"Invernizzi P, Crosignani A, Battezzati PM et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology. 1997. https:\/\/doi.org\/10.1002\/hep.510250507.","DOI":"10.1002\/hep.510250507"},{"key":"7122_CR22","doi-asserted-by":"crossref","unstructured":"Sakauchi F, Mori M, Zeniya M, Toda G. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol. 2006; 16:30\u20134.","DOI":"10.2188\/jea.16.30"},{"key":"7122_CR23","unstructured":"Zhang F-K, Jia J-D, Wang B-E. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int. 2004; 3:288\u2013291."},{"key":"7122_CR24","doi-asserted-by":"crossref","unstructured":"Kim WR, Poterucha JJ, Jorgensen RA et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology. 1997; 26:22\u20136.","DOI":"10.1002\/hep.510260103"},{"key":"7122_CR25","doi-asserted-by":"crossref","unstructured":"Joshi S, Cauch-Dudek K, Heathcote EJ et al. Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis? Am J Gastroenterol. 2002; 97:999\u20131002.","DOI":"10.1111\/j.1572-0241.2002.05620.x"},{"key":"7122_CR26","doi-asserted-by":"crossref","unstructured":"Juliusson G, Imam M, Bj\u00f6rnsson ES et al. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis. Scand J Gastroenterol. 2016; 51:745\u201352.","DOI":"10.3109\/00365521.2015.1132337"},{"key":"7122_CR27","doi-asserted-by":"publisher","unstructured":"Koulentaki M, Moscandrea J, Dimoulios P et al. Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment. Dig Dis Sci. 2004. https:\/\/doi.org\/10.1023\/B:DDAS.0000037811.48575.da.","DOI":"10.1023\/B:DDAS.0000037811.48575.da"},{"key":"7122_CR28","doi-asserted-by":"crossref","unstructured":"Zandanell S, Strasser M, Feldman A et al. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up. Postgrad Med. 2021:1\u20138.","DOI":"10.1080\/00325481.2021.1885945"},{"key":"7122_CR29","doi-asserted-by":"crossref","unstructured":"Michieletti P, Wanless IR, Katz A et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut. 1994; 35:260\u2013265.","DOI":"10.1136\/gut.35.2.260"},{"key":"7122_CR30","unstructured":"Lacerda MA, Ludwig J, Dickson ER et al. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol. 1995; 90:247\u2013249."},{"key":"7122_CR31","doi-asserted-by":"publisher","unstructured":"Kadokawa Y, Omagari K, Ohba K et al. Does the diagnosis of primary biliary cirrhosis of autoimmune cholangitis depend on the \u201cphase\u201d of the disease? Liver Int. 2005. https:\/\/doi.org\/10.1111\/j.1478-3231.2005.01078.x.","DOI":"10.1111\/j.1478-3231.2005.01078.x"},{"key":"7122_CR32","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Pobre P, Castellano G, Colina F et al. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? J. Clin. Gastroenterol. 1996; 23:191\u2013198.","DOI":"10.1097\/00004836-199610000-00007"},{"key":"7122_CR33","doi-asserted-by":"publisher","unstructured":"Vierling JM. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis. 2004. https:\/\/doi.org\/10.1016\/S1089-3261(03)00132-6.","DOI":"10.1016\/S1089-3261(03)00132-6"},{"key":"7122_CR34","doi-asserted-by":"crossref","unstructured":"Levy C, Bowlus CL. Role of Antinuclear Antibodies in Primary Biliary Cholangitis. Am J Gastroenterol. 2020; 115:1604\u20131606.","DOI":"10.14309\/ajg.0000000000000765"},{"key":"7122_CR35","doi-asserted-by":"crossref","unstructured":"Par\u00e9s A, Caballer\u00eda L, Rod\u00e9s J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology. 2006; 130:715\u201320.","DOI":"10.1053\/j.gastro.2005.12.029"},{"key":"7122_CR36","doi-asserted-by":"crossref","unstructured":"Corpechot C, Abenavoli L, Rabahi N et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008; 48:871\u20137.","DOI":"10.1002\/hep.22428"},{"key":"7122_CR37","doi-asserted-by":"crossref","unstructured":"Kumagi T, Guindi M, Fischer SE et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010; 105:2186\u201394.","DOI":"10.1038\/ajg.2010.216"},{"key":"7122_CR38","doi-asserted-by":"publisher","unstructured":"Corpechot C, Chazouillres O, Poupon R. Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011. https:\/\/doi.org\/10.1016\/j.jhep.2011.02.031.","DOI":"10.1016\/j.jhep.2011.02.031"},{"key":"7122_CR39","doi-asserted-by":"publisher","unstructured":"Nevens F, Andreone P, Mazzella G et al. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. N Engl J Med. 2016. https:\/\/doi.org\/10.1056\/nejmoa1509840.","DOI":"10.1056\/nejmoa1509840"},{"key":"7122_CR40","doi-asserted-by":"publisher","unstructured":"H\u00edndi M, Levy C, Couto CA et al. Primary biliary cirrhosis is more severe in overweight patients. J Clin Gastroenterol. 2013. https:\/\/doi.org\/10.1097\/MCG.0b013e318261e659.","DOI":"10.1097\/MCG.0b013e318261e659"},{"key":"7122_CR41","doi-asserted-by":"crossref","unstructured":"Bittencourt PL, Pal\u00e1cios SA, Farias AQ et al. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2003; 18:1061\u20131066.","DOI":"10.1046\/j.1440-1746.2003.03091.x"},{"key":"7122_CR42","doi-asserted-by":"publisher","unstructured":"Tanaka A, Leung PSC, Gershwin ME. The genetics of primary biliary cholangitis. Curr Opin Gastroenterol. 2019. https:\/\/doi.org\/10.1097\/MOG.0000000000000507.","DOI":"10.1097\/MOG.0000000000000507"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07122-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T19:24:08Z","timestamp":1656357848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07122-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["7122"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07122-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"13 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}